United Therapeutics (UTHR) PT Bumped to $203 at Wedbush Despite Top-Line Miss
Wedbush analyst Liana Moussatos reiterated an Outperform rating and lifted her price target on United Therapeutics Corp. (NASDAQ: UTHR) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
